Polycythemia Vera (PV): Update on Emerging Treatment Options

por Benevolo G, Vassallo F, Urbino I, Giai V
Publicado 2021

Complete hematological and major molecular response through treatment with low‐dose Interferon alpha 2a in high‐risk polycythemia vera patient: a case report

por Christoph Driessen, Christoph Noppen, Georg Boonen, Juergen Drewe
Publicado 2021

New Horizons in Myeloproliferative Neoplasms Treatment: A Review of Current and Future Therapeutic Options

por Domenico Penna
Publicado 2021

Ruxolitinib: a targeted treatment option for patients with polycythemia vera

por Vaddi K, Verstovsek S, Kiladjian JJ
Publicado 2016

An Abnormal Host/Microbiomes Signature of Plasma-Derived Extracellular Vesicles Is Associated to Polycythemia Vera

por Monica Barone, Monica Barone, Martina Barone, Francesca Ricci, Giuseppe Auteri, Giulia Corradi, Francesco Fabbri, Valentina Papa, Erika Bandini, Giovanna Cenacchi, Pier Luigi Tazzari, Nicola Vianelli, Silvia Turroni, Michele Cavo, Francesca Palandri, Marco Candela, Lucia Catani
Publicado 2021